Download PDF
Dtsch Med Wochenschr 2013; 138(05): 199-201
DOI: 10.1055/s-0032-1327345
Pneumologie | Commentary
Pneumologie, Onkologie
© Georg Thieme Verlag KG Stuttgart · New York

Pleuraerkrankungen: Neue Erkenntnisse und Entwicklungen

Recent advances in pleural diseases
K. Darwiche
1   Pneumologie – Universitäts- klinik, Ruhrlandklinik, Westdeutsches Lungenzentrum Essen
,
P. Zabel
2   Medizinische Klinik, Forschungszentrum Borstel
,
H. Teschler
1   Pneumologie – Universitäts- klinik, Ruhrlandklinik, Westdeutsches Lungenzentrum Essen
› Author Affiliations
Further Information

Publication History

Publication Date:
22 January 2013 (online)

Also available at
    Permissions and Reprints

Schlüsselwörter

Pleuramesotheliom - Pleuraempyem - Spontanpneumothorax - Pleurodese - maligner Pleuraerguss

Keywords

pleural mesothelioma - pleural empyema - spontaneous pneumothorax - pleurodesis - malignant pleural effusion
 

  • Literatur

  • 1 Agarwal R, Khan A, Agarwal AN et al. Efficacy and safety of iodopovidone pleurodesis. Indian J Med Res 2012; 135: 297-304
    PubMedGoogle Scholar
  • 2 Alrajhi K, Woo MY, Vaillancourt C. Test characteristics of ultrasonography for the detection of pneumothorax. Chest 2012; 141: 703-708
    CrossrefPubMedGoogle Scholar
  • 3 Bielsa S, Hernández P, Rodriguez-Panadero F et al. Tumor type influences the effectiveness of pleurodesis in malignant effusions. Lung 2011; 189: 151-155
    CrossrefPubMedGoogle Scholar
  • 4 Bridevaux PO, Tschopp JM, Cardillo G et al. Short-term safety of thoracoscopic talc pleurodesis for recurrent primary spontaneous pneumothorax: a prospective European multicentre study. Eur Respir J 2011; 38: 770-773
    CrossrefPubMedGoogle Scholar
  • 5 Cao GQ, Kang J, Wang F et al. Intrapleural instillation of autologous blood for persistent air leak in spontaneous pneumothorax in patients with advanced chronic obstructive pulmonary disease. Ann Thorac Surg 2012; 93: 1652-1657
    CrossrefPubMedGoogle Scholar
  • 6 Harvey I, Pass HI, Levin SM et al. Fibulin-3 as a Blood and Effusion Biomarker for Pleural Mesothelioma. N Engl J Med 2012; 367: 1417-1427
    CrossrefPubMedGoogle Scholar
  • 7 Hollevoet K, Reitsma JB, Creaney J et al. Serum mesothelin for diagnosing malignant pleural mesothelioma. J Clin Oncol 2012; 30: 1541-1549
    CrossrefPubMedGoogle Scholar
  • 8 MacDuff A, Arnold A, Harvey J. BTS Pleural Disease Guideline Group. Management of spontaneous pneumothorax: British Thoracic Society Pleural Disease Guideline 2010. Thorax 2010; 65 (Suppl. 02) ii18-31
    CrossrefPubMedGoogle Scholar
  • 9 Maskell N. British Thoracic Society Pleural Disease Guideline Group. British Thoracic Society Pleural Disease Guidelines – 2010 update. Thorax 2010; 65: 667-669
    CrossrefPubMedGoogle Scholar
  • 10 Menzies SM, Rahman NM, Wrightson JM et al. Blood culture bottle culture of pleural fluid in pleural infection. Thorax 2011; 66: 658-662
    CrossrefPubMedGoogle Scholar
  • 11 Mohsen TA, Zeid AA, Meshref M et al. Local iodine pleurodesis versus thoracoscopic talc insufflation in recurrent malignant pleural effusion. Eur J Cardiothorac Surg 2011; 40: 282-286
    PubMedGoogle Scholar
  • 12 Pass HI, Lott D, Lonardo F et al. Asbestos exposure, pleural mesothelioma, and serum osteopontin levels. N Engl J Med 2005; 353: 1564-1573
    CrossrefPubMedGoogle Scholar